Thus, our results suggest that, despite increased frequencies of circulating ICOS+ Tregs in AD, their efficacy of immunosuppression might be impaired due to reduced viability upon restimulation which would, in turn, lead to impaired production of IL‐10. The gene discussed is ICOS; the disease is Alzheimer disease.